Remote Psychological Intervention for COVID-19 Survivors With AKI and Caregivers (REPICOV-AKI)

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

July 1, 2024

Conditions
COVID-19AnxietyDepressive SymptomsAcute Kidney Injury
Interventions
BEHAVIORAL

Cognitive behavioral therapy

The investigator adapted the manual of psychological intervention based on Cognitive Behavioral Therapy (CBT) which previously was validated in patients with chronic kidney disease. Patients received CBT using a model of six modules, with a time of 60 minutes for each weekly session. For each module, a skill acquisition criterion was used, to know if the participants were putting the techniques into practice in their daily lives and to know if it was pertinent to move on to the next module. Modules were adapted to the needs of each participant. In consequence, the number of sessions was different for each patient. All participants had a follow-up session one month after they finished the psychological therapy. Additionally, a daily self-record of symptoms perception and a short questionnaire on the usefulness of each technique used were sent daily to the participants via a phone text message.

Trial Locations (1)

14080

National Institute of Respiratory Diseases, Mexico City

All Listed Sponsors
lead

Jesus Rivero, MD

OTHER_GOV

NCT06522776 - Remote Psychological Intervention for COVID-19 Survivors With AKI and Caregivers (REPICOV-AKI) | Biotech Hunter | Biotech Hunter